One of the richest persons in India and a millionaire businessman, Dilip Shanghvi was born on October 1st, 1955. Sun Pharmaceuticals was started by him.In 2016, the Indian government bestowed upon him the Padma Shri, a civic distinction. He was placed eighth on India Today magazine's list of the country's most influential persons in 2017. Shanghvi ranked sixth among Indian billionaires as of October 2023, according to Forbes, with a net worth of US$18.7 billion.
From a Gujarati Hindu Vaishnav Kapol Vania family living in Kolkata, Shanghvi is descended. He was born in the Indian state of Gujarat's small town of Amreli, the son of Shantilal and Kumud Shanghvi. The University of Calcutta awarded Shanghvi a Bachelor of Commerce degree. He grew up with his parents in the Burrabazar neighbourhood of Kolkata and attended college there. He received his education and graduated from Bhawanipur Education Society College, both of which are alumni of J. J. Ajmera High School.
Shanghvi began by assisting his father in his Kolkata-based firm, which involved the wholesale distribution of medications, primarily generic medications. He had the idea to start making his own medications rather than reselling those created by others while he was working on this project.
With a capital investment of INR 10,000, Shanghvi, then 27 years old, ultimately launched his first manufacturing facility in 1982. Sun Pharmaceutical Industries is the name of his business. The facility, which was close to Mumbai in his home state of Gujarat's Vapi, produced just one psychiatric medication. But because to Shanghvi's commercial sense and drive, things quickly took off, and by 1997, Sun Pharma had even managed to buy the American firm Caraco Pharma. In 2007, Sun also purchased Israel's Taro Pharma.
Israel Makov, a former CEO of Teva Pharmaceuticals, was selected by Shanghvi to succeed him as chairman and CEO when he stepped down in 2012; Managing Director Shanghvi was appointed. The majority shareholder of Ranbaxy, Daiichi Sankyo, and Sun reached an agreement in April 2014 under which Sun would pay $3.2 billion in Sun stock and $800 million in Ranbaxy debt in exchange for all of the company's outstanding shares. The transaction closed in March 2015, making Sun the largest drug company in India and the fifth-largest in the world. Daiichi became Sun's second-largest shareholder. He resigned as managing director of SPARC in May 2021, however he will still serve as chairman and a non-executive director of the company.
His wife is actress Vibha Shanghvi. Both of their children, a son named Aalok and a girl named Vidhi, are employed with Sun Pharmaceuticals. Shanghvi is a follower of Shrinathji and frequently travels with his family to the city of Nathdwara in Rajasthan, which is the deity's residence. The plant and offices of Sun Pharma are covered in images and idols of the god.